Skip to content

A randomized controlled study of digital cognitive training improving cognitive impairment after MECT in depression

A randomized controlled study of digital cognitive training improving cognitive impairment after MECT in depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068813
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder

Interventions

trial:5 training tasks recommended by the system every day, 8 minutes each time, 40 minutes a day, 4 days a week, and the training period was 8 weeks
contrl:The lowest difficulty perceptual training task pushed by the system, such as size matching task, etc. The comfort training group maintained the same frequency and length of training as the cogn

Sponsors

Beijing Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of depression (MDD) in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); 2. MECT was required for this hospitalization, and MECT had not been performed in the previous 12 months; 3. Hamilton Depression Scale (HDRS-17) >= 17 points and ECCA score >=23 points 24h before the first MECT treatment; 4. Compared with 24h before the first MECT treatment, the reduction rate of HDRS-17 at 48h after the last MECT treatment was >=50%, and the total reduction value of ECCA was >=4 points. 5. Age 18-55, male and female; 6. Education level above primary school; 7. The patient or the patient's legal guardian signed the written informed consent for MECT and signed the written informed consent for this study.

Exclusion criteria

Exclusion criteria: 1. Combined with serious physical diseases and diseases that may impair cognitive function (such as stroke, Parkinson's disease, AD/VD, etc.); 2. Subjects could not complete the MATRICS neurocognitive test set (MCCB) at baseline or the total MCCB score at baseline was lower than 40; 3. Subjects were pregnant or nursing, or planned to become pregnant during the study; 4. Participating in other research projects; 5. Receiving CCRT, cognitive correction, TMS and other treatments that may improve cognitive function.

Design outcomes

Primary

MeasureTime frame
ECCA Score;

Secondary

MeasureTime frame
MCCB score;EEG;

Countries

China

Contacts

Public ContactGang Wang

Beijing Anding Hospital

gangwangdoc@ccmu.edu.cn+86 173 0223 2650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026